Stockholders' Equity Attributable to Parent of Kura Oncology, Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary: Kura Oncology, Inc. quarterly Stockholders' Equity Attributable to Parent in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
Kura Oncology, Inc. Stockholders' Equity Attributable to Parent for the quarter ending 31 Dec 2025 was $174,135,000, a 58% decline year-over-year.
Source SEC data: View on sec.gov

Stockholders' Equity Attributable to Parent, Quarterly (USD)

Stockholders' Equity Attributable to Parent, YoY Quarterly Change (%)

Kura Oncology, Inc. Quarterly Stockholders' Equity Attributable to Parent (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$174,135,000	-$239,505,000	-58%	31 Dec 2025	10-K	05 Mar 2026	2025	FY
Q3 2025	$242,542,000	-$181,229,000	-43%	30 Sep 2025	10-Q	04 Nov 2025	2025	Q3
Q2 2025	$305,486,000	-$160,584,000	-34%	30 Jun 2025	10-Q	04 Nov 2025	2025	Q3
Q1 2025	$364,406,000	-$140,678,000	-28%	31 Mar 2025	10-Q	04 Nov 2025	2025	Q3
Q4 2024	$413,640,000	+$16,367,000	+4.1%	31 Dec 2024	10-K	05 Mar 2026	2025	FY
Q3 2024	$423,771,000	-$6,166,000	-1.4%	30 Sep 2024	10-Q	04 Nov 2025	2025	Q3
Q2 2024	$466,070,000	+$6,392,000	+1.4%	30 Jun 2024	10-Q	04 Nov 2025	2025	Q3
Q1 2024	$505,084,000	+$109,901,000	+28%	31 Mar 2024	10-Q	04 Nov 2025	2025	Q3
Q4 2023	$397,273,000	-$23,005,000	-5.5%	31 Dec 2023	10-K	05 Mar 2026	2025	FY
Q3 2023	$429,937,000	+$10,316,000	+2.5%	30 Sep 2023	10-Q	07 Nov 2024	2024	Q3
Q2 2023	$459,678,000	+$10,187,000	+2.3%	30 Jun 2023	10-Q	07 Nov 2024	2024	Q3
Q1 2023	$395,183,000	-$81,067,000	-17%	31 Mar 2023	10-Q	07 Nov 2024	2024	Q3
Q4 2022	$420,278,000	-$86,331,000	-17%	31 Dec 2022	10-K	05 Mar 2026	2025	FY
Q3 2022	$419,621,000	-$114,135,000	-21%	30 Sep 2022	10-Q	02 Nov 2023	2023	Q3
Q2 2022	$449,491,000	-$109,060,000	-20%	30 Jun 2022	10-Q	02 Nov 2023	2023	Q3
Q1 2022	$476,250,000	-$109,737,000	-19%	31 Mar 2022	10-Q	02 Nov 2023	2023	Q3
Q4 2021	$506,609,000	-$104,296,000	-17%	31 Dec 2021	10-K	28 Feb 2025	2024	FY
Q3 2021	$533,756,000	+$227,261,000	+74%	30 Sep 2021	10-Q	03 Nov 2022	2022	Q3
Q2 2021	$558,551,000	+$236,177,000	+73%	30 Jun 2021	10-Q	03 Nov 2022	2022	Q3
Q1 2021	$585,987,000	+$382,786,000	+188%	31 Mar 2021	10-Q	03 Aug 2022	2022	Q2
Q4 2020	$610,905,000	+$392,124,000	+179%	31 Dec 2020	10-K	27 Feb 2024	2023	FY
Q3 2020	$306,495,000	+$72,911,000	+31%	30 Sep 2020	10-Q	04 Nov 2021	2021	Q3
Q2 2020	$322,374,000	+$75,793,000	+31%	30 Jun 2020	10-Q	04 Nov 2021	2021	Q3
Q1 2020	$203,201,000	+$53,636,000	+36%	31 Mar 2020	10-Q	05 Aug 2021	2021	Q2
Q4 2019	$218,781,000	+$57,796,000	+36%	31 Dec 2019	10-K	23 Feb 2023	2022	FY
Q3 2019	$233,584,000	+$58,977,000	+34%	30 Sep 2019	10-Q	05 Nov 2020	2020	Q3
Q2 2019	$246,581,000	+$134,184,000	+119%	30 Jun 2019	10-Q	05 Nov 2020	2020	Q3
Q1 2019	$149,565,000	+$24,765,000	+20%	31 Mar 2019	10-Q	06 Aug 2020	2020	Q2
Q4 2018	$160,985,000	+$81,120,000	+102%	31 Dec 2018	10-K	24 Feb 2022	2021	FY
Q3 2018	$174,607,000	+$85,408,000	+96%	30 Sep 2018	10-Q	05 Nov 2019	2019	Q3
Q2 2018	$112,397,000	+$68,760,000	+158%	30 Jun 2018	10-Q	05 Nov 2019	2019	Q3
Q1 2018	$124,800,000	+$74,559,000	+148%	31 Mar 2018	10-Q	01 Aug 2019	2019	Q2
Q4 2017	$79,865,000	+$22,989,000	+40%	31 Dec 2017	10-K	24 Feb 2021	2020	FY
Q3 2017	$89,199,000	+$25,533,000	+40%	30 Sep 2017	10-Q	07 Nov 2017	2017	Q3
Q2 2017	$43,637,000	-$26,404,000	-38%	30 Jun 2017	10-Q	07 Aug 2017	2017	Q2
Q1 2017	$50,241,000	-$25,825,000	-34%	31 Mar 2017	10-Q	15 May 2017	2017	Q1
Q4 2016	$56,876,000	-$25,227,000	-31%	31 Dec 2016	10-K	25 Feb 2020	2019	FY
Q3 2016	$63,666,000	+$25,882,000	+68%	30 Sep 2016	10-Q	07 Nov 2016	2016	Q3
Q2 2016	$70,041,000	+$26,717,000	+62%	30 Jun 2016	10-Q	10 Aug 2016	2016	Q2
Q1 2016	$76,066,000	+$27,172,000	+56%	31 Mar 2016	10-Q	11 May 2016	2016	Q1
Q4 2015	$82,103,000	+$85,536,000		31 Dec 2015	10-K	12 Mar 2018	2017	FY
Q3 2015	$37,784,000	+$37,927,038		30 Sep 2015	10-Q	13 Nov 2015	2015	Q3
Q2 2015	$43,324,000	+$43,460,610		30 Jun 2015	10-Q	14 Aug 2015	2015	Q2
Q1 2015	$48,894,000	+$49,023,723		31 Mar 2015	10-Q	13 May 2015	2015	Q1
Q4 2014	$3,433,000	-$3,309,043		31 Dec 2014	10-K	14 Mar 2017	2016	FY
Q3 2014	$143,038^*	-$28,831		30 Sep 2014	10-Q	14 Nov 2014	2014	Q3
Q2 2014	$136,610^*	-$28,542		30 Jun 2014	10-Q	14 Aug 2014	2014	Q2
Q1 2014	$129,723^*	+$101,189,277		31 Mar 2014	10-Q	15 May 2014	2014	Q1
Q4 2013	$123,957^*	+$95,222,043		31 Dec 2013	10-K	27 Feb 2015	2014	FY
Q3 2013	$114,207^*	+$85,569,793		30 Sep 2013	10-Q	14 Nov 2013	2013	Q3
Q2 2013	$108,068^*	+$79,562,932		30 Jun 2013	10-Q	14 Aug 2013	2013	Q2
Q1 2013	$101,319,000	-$27,916,000	-38%	31 Mar 2013	10-Q	15 May 2013	2013	Q1
Q4 2012	$95,346,000	-$95,277,969		31 Dec 2012	10-K	27 Feb 2015	2014	FY
Q3 2012	$85,684,000	-$85,624,853		30 Sep 2012	10-Q	14 Nov 2012	2012	Q3
Q2 2012	$79,671,000	-$79,618,120		30 Jun 2012	10-Q	14 Aug 2012	2012	Q2
Q1 2012	$73,403,000	-$73,334,969		31 Mar 2012	10-Q	15 May 2012	2012	Q1
Q4 2011	$68,031^*	-$27,040		31 Dec 2011	10-K	27 Feb 2015	2014	FY
Q3 2011	$59,147^*			30 Sep 2011	10-Q	14 Nov 2011	2011	Q3
Q2 2011	$52,880^*			30 Jun 2011	10-Q	15 Aug 2011	2011	Q2
Q1 2011	$68,031^*			31 Mar 2011	10-Q	15 May 2012	2012	Q1
Q4 2010	$40,991^*			31 Dec 2010	10-K	27 Feb 2015	2014	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.